The Ethical Implications of Cognitive Enhancers [PDF]
, 2021 This review will explore the ethical use of cognitive enhancers which alter and improve cognitive function and performance. Cognitive enhancers are not only used in the treatment of certain cognitive disorders, such as schizophrenia and attention deficit
Tejani-Butt, Shanaz, Shearouse, Sydney
core +1 more source
Cognitive enhancers derived from edible crops [PDF]
, 2020 The concept of an effective cognitive boosting nootropic supplement is gaining traction with consumers, neuroscientists and regulators alike and it is therefore unsurprising that scientifically validated Nootropics are highly prized.
Chapman, Natalie, Fisk, Ian
core +5 more sources
CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
, 2022 Introduction Cognitive enhancers (ie, cholinesterase inhibitors and memantine) can provide symptomatic benefit for some individuals with dementia; however, there are circumstances in which the risks of continuing treatment may potentially outweigh ...
Julia Kirkham +25 more
core +1 more source
Perfectionism and attitudes toward cognitive enhancers (“smart drugs”) [PDF]
, 2016 Perfectionism is a personality disposition characterized by exceedingly high standards of performance and pressure to be perfect which may incline students to take cognitive enhancers (“smart drugs”) to boost their academic performance.
Stoeber, Joachim, Hotham, Sarah
core +1 more source
Efficacy of different types of cognitive enhancers for patients with schizophrenia. A meta-analysis [PDF]
, 2018 Cognitive impairment is a core feature of schizophrenia, which is predictive for functional outcomes and is, therefore, a treatment target in itself. Yet, literature on efficacy of different pharmaco-therapeutic options is inconsistent. This quantitative
Begemann M. +11 more
core +3 more sources
Working smart: the use of ‘cognitive enhancers’ by UK University students
, 2020 Cognitive enhancers include a wide range of substances including prescription medication for attentional deficient disorders and pharmacological substances for cognitive augmentation. Students have recently been identified as the largest cohort of users.
Harry Lane (8739282) +2 more
core +2 more sources
Efficacy of cognitive enhancers for Alzheimer’s disease: protocol for a systematic review and network meta-analysis [PDF]
, 2018 Background Approximately 35 million people world-wide have Alzheimer’s disease and this is projected to nearly double by 2030. Cognitive enhancers, including cholinesterase inhibitors (for example, donepezil, galantamine and rivastigmine)
Lillie, Erin +8 more
core +2 more sources
Use of cognitive enhancers among medical students in Lithuania
, 2017 Reikšminiai žodžiai: Medicinos studentai; Narkotikų vartojimas; Pažintinių gebėjimų gerinimas; Pscihogtropinės medžiagos; Psichotropinės priemonės; Studentai; Cognitive enhancers; Drug misuse; Lithuania; Neuro-enhancement; StudentsAims - The purpose of ...
Strumila, Robertas +2 more
core +2 more sources
Cognitive enhancers : molecules, mechanisms and minds
, 2013 This issue of Neuropharmacology is devoted to the topic of cognitive enhancers, arguably one of the most contentious issues in modern neuroscience: could we, should we, pharmacologically enhance human cognitive performance?
Frenguelli, Bruno G.
core +1 more source
Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms [PDF]
, 2019 Epigenetic control of enhancers alters neuronal functions and may be involved in Alzheimer’s disease (AD). Here, we identify enhancers in neurons contributing to AD by comprehensive fine-mapping of DNA methylation at enhancers, genome-wide.
Wang, Ting +17 more
core +2 more sources